rofecoxib信息详情
罗非考昔<抗关节炎药，cox-2抑制药>
professional advice───专业建议
assistant professor───n.助理教授（级别高于讲师而低于副教授）
medical professional───医学专家；[医]医学专业人员；医疗技术人员
professed means───公开的手段
professions in shadowlands───暗地职业
professor trelawney───特里劳尼教授
professing definition───公开的定义
adjunctive professor───副教授
learned professor───有学问的教授
professes clue───承认线索
MI rate ratio with rofecoxib use was 1.59 in patients with a prior MI and 1.23 in those without a previous MI.───罗非昔布并且有心梗病史的患者心梗发生率为1.59%，而没有心梗病史的患者心梗发生率只有1.23%。
The findings also support prior research linking rofecoxib (Vioxx) with adverse cardiovascular effects.───该研究也支持以前关于罗非考昔（Vioxx）与心血管副作用相关的结论。
Rofecoxib users had the highest event rates, while naproxen users had the lowest, even lower than non users.───罗非考昔使用者的心血管事件发生率最高，而萘普生的发生率最低，甚至比不应用药物的人还要低。
A few weeks later, during treatment with rofecoxib, a relapse appeared, including purpura.───几周后，治疗期间与罗非昔布，出现复发，包括紫癜。
Unfortunately, cardiovascular side-effects have recently been reported in patients using another selective COX-2 inhibitor, rofecoxib.───然而，最近有报道显示应用另一种选择性COX-2抑制剂-罗非昔布-的患者中有心血管副作用的发生。
The diagnosis of rofecoxib-induced cutaneous vasculitis was confirmed by regression of all symptoms when treatment stopped.───诊断中的罗非昔布引起皮肤血管炎证实了回归的所有症状在治疗停止。
The role of selective COX-2 inhibitors in patients with FAP is controversial because of cardiovascular side-effects reported for rofecoxib.───由于罗非昔布的心血管副作用，在家族性腺瘤性息肉病患者中应用选择性COX-2抑制剂仍存在争议。